Introduction
============

When phagocytic cells encounter bacteria, they have the ability to engulf them and transport them inside a vacuole called a phagosome ([Fig. 1 A](#fig1){ref-type="fig"}), a compartment that has similarities with early endosomes and will sequentially acquire host proteins that regulate biogenesis and transport of this organelle ([@bib36]). Rab5 is a GTPase critical for early membrane transport decisions after phagocytosis. Activated Rab5 is recruited at the phagosome shortly after phagocytosis and is necessary for maturation of the phagosome through the recruitment of a large number of effector proteins. Rab5 is replaced by Rab7 in a process called Rab conversion, which is required for the subsequent fusion of the phagosome with lysosomes to generate the phagolysosome ([@bib53]). The phagolysosome is acidic and enriched in proteases, conditions that promote bacterial degradation.

![***Mtb* and *S.* Typhimurium manipulate the fate of their vacuole through modification of phosphoinositide metabolism.** (A) Normal maturation of a phagosome containing nonpathogenic bacteria. After phagocytosis, bacteria reside in a vacuole showing similarities with early endosomes, notably presenting the small GTPase Rab5. Rab5 recruits the PI3 kinase hVPS34 that produces PI3P at the phagosome surface. The presence of PI3P is required for the maturation of the phagosome to phagolysosome by the recruitment of a subset of proteins, including EEA1. (B) *Mtb* creates a replicative niche by manipulating PI3P metabolism. *Mtb* blocks the activation of hVPS34 at its vacuole by ManLAM, thereby preventing PI3P production. The mechanism for this block involves the inhibition of Ca^2+^ rise, which is necessary for hVPS34 activation through a cascade involving calmodulin. Moreover, *Mtb* secretes SapM, a phosphatase that could be involved in depleting the vacuole from any residual PI3P. Finally, *Mtb* can expand its vacuole by recruitment of endosome vesicles. This recruitment could be achieved by the *Mtb* lipid PIM, a phosphoinositide analogue. (C) The *S.* Typhimurium T4SS effector SopB generates PI3P at the vacuole membrane. A possible mechanism for PI3P enrichment at the early *S.* Typhimurium vacuole is an indirect modulation of hVPS34 recruitment by SopB. This results in a prolonged and increased presence of PI3P at the vacuole surface. The presence of a high amount of PI3P induces subsequent recruitment of PI3P-binding proteins, including SNX1, SNX3, and PIKfyve, which were shown to be required for the maturation of the *S.* Typhimurium--containing vacuole (SCV).](JCB_201105019_RGB_Fig1){#fig1}

Pathogenic intracellular bacteria have evolved different strategies to counteract the endocytic pathway and avoid being degraded in lysosomes. Some bacteria, such as *Coxiella burnetii*, are able to survive in a compartment that is derived from fusion of the vacuole with lysosomes ([@bib69]). Other bacteria have acquired mechanisms to escape the lysosomal pathway. *Shigella flexneri* and *Listeria monocytogenes* escape from the phagosome before lysosome fusion to reach the cytosol of the host, where they can replicate intracellularly ([@bib20]). Many bacteria, such as *Salmonella enterica* serovar Typhimurium or *Legionella pneumophila*, actively modify host vesicular transport pathways to prevent the fusion of the vacuole in which they reside with lysosomes, a process that is necessary for creating a specialized organelle favorable for replication. Most of these bacteria use a T3SS (type III secretion system) or T4SS (type IV secretion system) to modulate membrane transport and create specialized vacuoles. These secretion systems enable the bacteria to translocate proteins known as effectors across the vacuolar membrane where they can then manipulate host proteins residing in the cytoplasm or on other cellular organelles.

Studying the mechanisms used by pathogenic bacteria to subvert their host pathways has two main objectives. First, an understanding of how these effector proteins function provides important insight into the mechanism of host cell infection and could lead to the development of new therapeutic approaches to target these pathogens. Second, because bacteria disrupt eukaryotic processes, they can be used as tools to dissect eukaryotic pathways. Reports coming from studies on many different pathogens show that vesicular transport pathways are manipulated in diverse ways by intracellular bacteria, and understanding how bacteria manipulate these pathways could provide a deeper understanding of the homeostatic regulation of membrane transport in eukaryotic cells. Thus, this review will focus on general strategies used by different bacteria to create a specialized organelle that promotes survival and replication, with specific examples falling into the broad context of pathogen manipulation of the phosphoinositide composition of membranes, manipulation of the host cytoskeleton, and modulation of small GTPases.

Phosphoinositide subversion by vacuolar pathogens
=================================================

Lipid subversion by pathogens is emerging as a process critical for microbial infection ([@bib63]). Bacteria are able to subvert host lipids for metabolism or for the formation of the vacuoles in which they reside. In many pathogens, effector proteins that can sense host lipids and modify the phosphoinositide signatures on membranes are being found to play critical roles in controlling vesicular transport in the cell.

Phosphatidylinositol (PI) phosphates (PIPs) have important functions in regulating pathways involved in signal transduction and in vesicular transport ([@bib11]). PIPs phosphoinositol ring can be reversibly phosphorylated at positions 3, 4, and 5, which can generate up to seven different PIP species. The PIP signatures on the membrane mediate organelle-specific recruitment of proteins that regulate vesicular transport. Specific kinases and phosphatases act in concert to tightly regulate the phosphorylation state of the PIPs, so the regulation of the localization of these enzymes is critical for controlling vesicular transport in the cell. Pathogens have evolved mechanisms to modify membrane signatures both directly and indirectly by controlling the phosphorylation state of PIPs on the vacuoles in which they reside, which is critical for modulating the transport of this pathogen-occupied organelle ([@bib70]).

The species PI(4,5)P2 and PI(3,4,5)P3 are mainly found at the plasma membrane and are critical for recruiting the cellular machinery important for phagocytosis ([Fig. 1 A](#fig1){ref-type="fig"}). Once phagosomes have been formed, the major PIP species found on the organelle is PI3P ([@bib36]). Proteins containing PI3P recognition motifs are recruited to the endosome, inducing maturation to the late endosomal and phagolysosomal stages. Bacteria have evolved different mechanisms to manipulate the levels of PI3P on vacuole membranes. *Mycobacterium tuberculosis* (*Mtb*) aims to decrease PI3P level on the vacuole to prevent maturation of the phagosome at an early stage in endocytic transport, whereas *S.* Typhimurium increases PI3P levels on the vacuole to stimulate biogenesis of a unique compartment with properties of late endosomes.

PI3P depletion by *Mtb*.
------------------------

*Mtb* survives in host cells by delaying phagosome maturation at an early stage ([Fig. 1 B](#fig1){ref-type="fig"}). Vacuoles containing *Mtb* are enriched for Rab5 but largely devoid of Rab7, suggesting that endocytic maturation of this compartment is stalled shortly after fusion with early endosomes in the cell ([@bib67]). Mechanisms by which *Mtb* controls membrane transport appear to be diverse and are still not fully understood. Many bacterial factors, proteins as well as lipids, have been associated with the impairment of the vacuole to mature ([@bib51]). Interestingly, even in the presence of Rab5, it was shown that the Rab5 effectors EEA1 ([@bib15]) and Hrs ([@bib68]), both PI3P-binding regulatory proteins, fail to accumulate on the *Mtb*-containing vacuole (MCV) and that the absence of these factors impairs endocytic maturation of this vacuole. Consistent with PI3P being important for the localization of proteins involved in the maturation of early endosomal compartments, levels of PI3P on vacuoles containing live *Mtb* were shown to be reduced compared with vacuoles containing beads or dead bacteria ([@bib52]; [@bib66]), indicating that *Mtb* can actively prevent the acquisition or deplete PI3P from the vacuole in which it resides.

Two complementary strategies appear to be used by *Mtb* to reduce PI3P levels on the MCV. The mycobacteria-derived lipid mannose-capped lipoarabinomannan (ManLAM) arrests maturation of the MCV by a mechanism that involves suppression of the PI3 kinase hVPS34, the kinase involved in PI3P production in early endosomes ([Fig. 1 B](#fig1){ref-type="fig"}; [@bib16]). ManLAM suppresses hVPS34 by interfering with Ca^2+^ fluxes, which induce a signaling cascade that activates hVPS34 (and therefore PI3P production) at the phagosome membrane ([@bib64]). Nevertheless, increasing intracellular Ca^2+^ in the cell is not sufficient to restore PI3P level on the phagosome, suggesting that *Mtb* has additional activities that suppress endosomal maturation ([@bib66]). SapM is a phosphatase produced by *Mtb* that can dephosphorylate PI3P in vitro ([@bib66]). SapM is secreted by *Mtb* and is sufficient to block phagosome--late endosome fusion in vitro in a PI3P-dependent mechanism. Phosphate consumption by a bacterial protein may then represent another mechanism used by *Mtb* to decrease PI3P levels on the vacuole.

It is intriguing that the *Mtb* vacuole recruits early endosomal vesicles while blocking fusion with late endosomes and lysosomes. *Mtb* produces a surface lipid called PI mannoside (PIM) that is very similar to PIPs. PIM has been shown to induce fusion of the phagosome with early endosomes in vitro and in vivo ([@bib65]), and it is thought that PIM-stimulated fusion of early endosomes helps maintain vacuole integrity to balance the inhibitory activities that prevent acquisition of additional membranes through fusion with late endosomes and lysosomes.

Although the SapM protein is secreted by *Mtb* ([@bib66]), and the lipids ManLAM and PIM have been reported to cross the vacuole membrane ([@bib4]), whether these products exert their function at the cytosolic face of the vacuole membrane remains unclear. Another possibility is that SapM and the lipids ManLAM and PIM alter the biophysical properties of the vacuole membrane from the luminal side of the compartment ([@bib65], [@bib66]).

PI metabolism by the *S.* Typhimurium SopB protein.
---------------------------------------------------

*S.* Typhimurium is also able to subvert normal trafficking to the phagolysosome compartment, even though a study indicates at least a partial fusion with lysosomes ([@bib12]). Effectors delivered by two different pathogenicity island-encoded T3SSs are critical for the development of the *S.* Typhimurium--containing vacuole (SCV) and for creating an organelle that permits intracellular survival ([@bib2]).

SopB is a T3SS effector with homology to eukaryotic inositol phosphatases and was shown to have a phosphatase activity against different PIPs in vitro ([@bib48]). Vacuoles containing *S.* Typhimurium acquire PI3P very rapidly after phagocytosis, and PI3P remains associated with the vacuole for an extended period ([Fig. 1 C](#fig1){ref-type="fig"}). In contrast, a *ΔsopB* strain resides in a vacuole that contains PI3P only transiently ([@bib25]). SopB seems sufficient for generating PI3P on vacuoles, given that expression of the SopB protein in mammalian cells will induce the formation of large macropinocytic vesicles on which PI3P is present ([@bib25]).

The mechanism of PI3P production by SopB is unclear. It has been suggested that PI3P results from the phosphatase activity of SopB on PI(3,5)P2 and PI(3,4,5)P3. However, it has also been shown that generation of PI3P on the SCV is sensitive to wortmannin, which blocks host PI3P kinase activity, suggesting PI3P originates from host phosphorylation of PI. This may indicate that SopB indirectly recruits the PI3P kinase hVPS34 at the SCV ([@bib41]), perhaps by creating PIP signatures that enhance the recruitment of hVPS34 regulators, including Rab5. Recent data may provide insight into why PI3P generation would benefit maturation of the SCV. Sorting nexin 1 ([@bib8]) and sorting nexin 3 ([@bib6]) are recruited to the SCV in a PI3P- and SopB-dependent manner ([Fig. 1 C](#fig1){ref-type="fig"}). These host regulators of membrane transport are required for normal replication of *S.* Typhimurium in cells. It has also been shown that the recruitment of the PtdIns(5) kinase PIKfyve, an effector of PI3P, to the SCV is required for the formation of the SCV ([@bib35]). Lastly, it has been suggested that the change in electrostatic charge at the surface of the SCV resulting from activities mediated by SopB could be sufficient to alter the recruitment of specific effectors ([@bib3]).

The activities of SopB also assist in the process of *S.* Typhimurium uptake by nonphagocytic cells ([@bib62]; [@bib9]). Interestingly, SopB possesses multiple ubiquitination sites, and a recent study indicates that the ubiquitination state of the protein allows the protein to have distinct functions by affecting the localization of SopB to membranes ([@bib50]). Ubiquitination of SopB has been shown to be important for localization of the protein to the SCV and for promoting the recruitment of Rab5 to the vacuole, but ubiquitination of SopB does not appear to be needed for the activities that promote bacterial entry. Thus, this *S.* Typhimurium effector utilizes the host posttranslational modification machinery to spatially regulate functions that affect different host cell processes.

Subversion of the cytoskeleton by vacuolar pathogens
====================================================

Central to most membrane transport processes are the movement of vesicles and tubules along the actin and microtubule cytoskeleton ([@bib58]). There are now several documented examples in which pathogenic bacteria target the cytoskeleton to modulate vacuole biogenesis and maintain an organelle that supports their intracellular survival. These strategies involve control over host processes that are central to the assembly of cytoskeletal networks and modulation of the motor proteins that transport cargo along these structures.

In certain host cells, the vacuoles containing *S.* Typhimurium will display long membrane tubules called *S.* Typhimurium--induced filaments (SIFs; [Fig. 2](#fig2){ref-type="fig"}; [@bib19]). Although several *S.* Typhimurium T3SS effectors are present on the SIFs, one effector called SifA is necessary for the formation of these structures ([@bib55]). The SifA protein was found to interact directly with the human protein SKIP ([@bib5]; [@bib49]), which is a host protein that binds to the motor protein kinesin-1 ([@bib5]). SKIP appears to function as a linker that regulates kinesin-1 on the Golgi apparatus and late endosomal and lysosomal compartments ([@bib13]). Structural studies have shown that SifA also has a domain that mediates interactions with the Rho family GTPases, and this interaction may activate these proteins by stimulating the exchange of GDP for GTP ([@bib49]). Thus, SifA may generate membrane filaments by coordinating both cytoskeleton dynamics and transport of membranes by host motor proteins along these structures, which could provide insight into how host proteins control vesicular transport processes that involve membrane tubules.

![**Intracellular bacteria subvert the eukaryotic cytoskeleton to create a replicative niche.** Two representative examples are depicted here. *S.* Typhimurium uses microtubules to form SIFs. SIFs are typical structures of the SCV. The mechanism of their formation, which involves microtubules, is not completely understood. At least two T3SS effectors, SifA and PipB2, play a role in SIF formation. They target the mammalian proteins SKIP and kinesin-1 and altogether induce protrusion and expansion of tubules from the SCV. *C. trachomatis* actively induces polymerization of actin and intermediate filaments to consolidate its large vacuole. This relies on an unknown bacterial effector and the host GTPase RhoA.](JCB_201105019_RGB_Fig2){#fig2}

A second T3SS effector called PipB2 was also found to be important for generating SIFs during infection, as an *S.* Typhimurium mutant deficient for PipB2 was found to occupy vacuoles with shorter SIFs ([@bib37]). PipB2 also interacts with kinesin-1 ([@bib24]) and may participate in the recruitment of this motor to the SCV. Thus, it is thought that SifA and PipB2 assist in the positioning of the SCV and can regulate the transport of membranes between the SCV and host organelles by spatially controlling the activity of kinesin-1 and modulating cytoskeletal dynamics by regulating Rho GTPase functions. However, the mechanisms that underlie SIF dynamics are probably more complex as genetic experiments indicate that several other effectors are involved in SCV biogenesis and transport ([@bib55]). Further characterization of *S.* Typhimurium effectors and their targets in eukaryotic cells could then lead to a better understanding of specific cytoskeleton-driven membrane transport in eukaryotes.

*Chlamydia trachomatis* occupies a vacuole that diverges from the endocytic pathway shortly after these bacteria are internalized and creates a replicative organelle intimately associated with the Golgi apparatus that is called an inclusion. Subversion of the cytoskeleton is central to the transport and maintenance of the *C. trachomatis* inclusion, and several mechanisms for *C. trachomatis* subversion of the cytoskeleton have been revealed. During entry, *C. trachomatis* induces actin polymerization using a type III effector protein called TARP, which contains actin-binding regions that facilitate actin polymerization and are important for bacterial uptake ([@bib14]; [@bib31]; [@bib39]). Shortly after uptake, the vacuoles containing *C. trachomatis* are transported on microtubules by a dynein-dependent, but dynactin-independent, mechanism ([@bib21]). *C. trachomatis* then utilizes actin and intermediate filaments to form a scaffold that surrounds the mature inclusion in a process that is dependent on RhoA ([Fig. 2](#fig2){ref-type="fig"}; [@bib38]). Disruption of the cytoskeletal framework that surrounds the inclusion leads to destabilization of the vacuole and fragmentation of this organelle. Lastly, *C. trachomatis* egress from cells also involves subversion of host actin regulators, namely, Wiskott--Aldrich syndrome protein, myosin, and Rho GTPases ([@bib29]). Thus, manipulation of the host cytoskeleton is essential for the biogenesis, maintenance, and eventual egress of *C. trachomatis* from the specialized vacuole it creates in host cells.

GTPase manipulation by pathogens
================================

Small GTPases are critical regulators of most host cellular processes, including the sorting and transport of cargo inside vesicles. The Rab and ADP ribosylation factor (ARF) families of small GTPases are highly conserved regulators of membrane transport, and the Rho family of GTPases is a critical regulator of the cytoskeleton. These GTPases have several common features. They are lipidated to facilitate their association with membranes. They are activated by guanine nucleotide exchange factors (GEFs) that stimulate GDP for GTP exchange and deactivated by GTPase-activating proteins (GAPs) that stimulate GTP hydrolysis. Activated GTPases recruit cellular proteins to membranes and create the protein complexes that promote membrane transport and changes to the cytoskeleton at the sites of activation. Activated GTPases can also recruit effectors that have signaling functions and modulate gene expression. Thus, GTPases provide an attractive target for pathogen manipulation, and there are now several well-documented examples of how intracellular pathogens have evolved specific mechanisms to manipulate the function of host GTPases. The two general themes that are observed are strategies for pathogens to subvert the function of GTPases by using effectors that function as activators ([Fig. 3 A](#fig3){ref-type="fig"}) and those that interfere with the signaling capacity of GTPases ([Fig. 3 B](#fig3){ref-type="fig"}).

![**Pathogens manipulate host GTPases.** (A) Positive regulation of host GTPases. The *S.* Typhimurium effector SopE binds and activates Rho/Rac/Cdc42 GTPases, thereby stimulating assembly of an actin-based network at the plasma membrane. SopE acts as a GEF and catalyzes the exchange of GTP for GDP. Similarly, the *L. pneumophila* effector DrrA functions as a GEF for the small GTPase Rab1 (a key GTPase involved in ER to Golgi and intra-Golgi vesicular transport) and activates it on the LCV. (B) Negative regulation of host GTPases. Bacteria have evolved several ways to negatively regulate GTPases. First, bacteria encode GAPs, such as SptP and LepB, to catalyze the hydrolysis of GTP to GDP to inactivate GTPases. Second, bacteria encode enzymes, such as VopS, IbpA, and DrrA, that inhibit downstream signaling of GTPases by posttranslationally modifying them with AMP. AMPylated Rac failed to interact with its effector p21-activated kinase (PAK). Similarly, AMPylated Rab1 was unable to bind to its effector MICAL-3 (microtubule-associated monoxygenase, calponin, and LIM domain containing 3). Recently, the *L. pneumophila* effector SidD has been shown to act on Rab1 to remove this AMP modification. Third, a novel modification on Rab1 and Rab35 was reported whereby the *L. pneumophila* effector AnkX modified the class II switch region of the Rabs with a phosphocholine moiety. This modification was observed in Rabs bound to both GDP and GTP. Phosphocholination of Rab35-GDP prevented its binding to its GEF connecdenn (CD). Finally, effectors such as YopT function as proteases to cleave Rho GTPases to inhibit their function.](JCB_201105019_RGB_Fig3){#fig3}

Activation of GTPases by bacterial effectors.
---------------------------------------------

Intracellular pathogens activate host GTPases as a strategy to promote internalization into a membrane-bound compartment and to alter the biochemical properties of the vacuole to modulate transport and fusion. *L. pneumophila* is an intracellular pathogen that uses a T4SS called Dot/Icm to create a vacuole that avoids fusion with late endosome and lysosome and is remodeled into an ER-derived organelle through subversion of membranes in the early secretory pathway of the host. A unique feature of the *L. pneumophila*--containing vacuole (LCV) is the localization of several small GTPases found on early secretory vesicles, including Rab1 and ARF1, which typically are not enriched on phagosomes ([@bib46]; [@bib34]). Expression of dominant-negative Rab1 or inactivation of ARF1 by brefeldin A inhibits formation of a vacuole that supports intracellular replication of *L. pneumophila*, indicating that these GTPases are functioning in the transport and fusion of the pathogen-occupied vacuole ([@bib33]; [@bib10]).

Consistent with the function of these GTPases being important for biogenesis of the LCV, two different T4SS effector proteins from *L. pneumophila* have been shown to have GEF activity. The protein RalF activates ARF GTPases and is required for the recruitment of ARF1 to the LCV ([@bib46]). Similar to host proteins that function as GEFs for ARF, the RalF protein has a Sec7 domain that mediates the nucleotide exchange reaction, indicating that this effector was likely acquired recently by the pathogen through a horizontal gene transfer mechanism, and through divergent evolution, this protein can now function to subvert ARF function during infection of host cells by *L. pneumophila*. The protein DrrA (also known as SidM) is a Rab1 GEF ([Fig. 3 A](#fig3){ref-type="fig"}) that is required for the recruitment of this GTPase to the LCV ([@bib40]; [@bib45]). Unlike RalF, which has a GEF domain that is highly similar to the GEF domain found in host activators of ARF, the DrrA GEF domain has no sequence or structural similarities to any known eukaryotic Rab GEFs but interacts precisely with the switch regions of Rab1 to function as a highly specific GEF for this GTPase ([@bib40]; [@bib30]; [@bib54]; [@bib60]; [@bib73]). DrrA also contains a structurally defined PI4P-binding domain that mediates association of the effector protein with the vacuole in which *L. pneumophila* resides ([@bib7]; [@bib54]; [@bib73]). Thus, convergent evolution has resulted in a bacterial protein that subverts the PI signature on the LCV membrane to specifically recruit and activate Rab1 on the vacuole in which the pathogen resides.

The *S.* Typhimurium T3SS effector SopE was one of the first bacterial proteins shown to function directly as an activator of small GTPases ([@bib22]). SopE is important for stimulating membrane ruffling during *S.* Typhimurium contact with epithelial cells. *S.* Typhimurium caught in membrane ruffles are engulfed and localize inside of macropinocytic vesicles inside the host cell. Biochemical analysis of SopE revealed that this bacterial protein could bind and activate the GTPases Rac1 and Cdc42 by inducing a conformational change in their switch region to catalyze the exchange of GDP for GTP ([Fig. 3 A](#fig3){ref-type="fig"}). Activation of the GTPase at the site of bacterial contact would then promote the membrane ruffling process by stimulating assembly of an actin-based network at the plasma membrane, mimicking signals that lead to the formation of filopodial extensions. Additional biochemical studies found that SopE has a close homologue called SopE2 that is specific for Cdc42 ([@bib17]). It has also been reported that SopE can act as a GEF for Rab5 ([@bib42]), although Rab5 activation by *S.* Typhimurium is likely to be controlled indirectly though the activities of other effectors, including SopB, as previously described ([@bib41]). Regardless, it is clear that signaling pathways initiated through the activation of Rac1 and Cdc42 by SopE are important for biogenesis of the early vacuole compartment in which *S.* Typhimurium resides, demonstrating how a bacterial GEF can be used to create a unique pathogen-occupied vacuole in cells that are normally nonphagocytic.

Interestingly, several type III effectors that contain a WxxxE motif were found to regulate cellular dynamics controlled by host GTPases ([@bib1]). Ectopic expression of *S. flexneri* effectors IpgB1 and IpgB2 led to formation of stress fibers and membrane ruffles ([@bib1]), structures that are regulated by RhoA, suggesting that these effectors could either mimic or activate Rho-dependent processes. Likewise, coexpression of the WxxxE effector SifA from *S.* Typhimurium with the effector SseJ induced tubulation of endosomes, similar to that induced by constitutively active RhoA expressed together with SseJ, indicating that SifA either mimics or activates a RhoA family GTPase ([@bib49]). Clarity on a possible mechanism underlying the function of these effectors was provided when the SifA structure revealed that the C terminus has a fold comparable with the GEF domain in SopE, suggesting that SifA may also have GEF activity. This could explain how this effector promotes changes in the host cytoskeleton that are similar to those observed upon expression of an active RhoA protein ([@bib49]). In addition, SifA interacted with GDP-bound RhoA, similar to SopE and other GEFs. This GEF paradigm was further supported by data showing that the enteropathogenic *Escherichia coli* WxxxE motif protein Map could modulate actin dynamics by functioning as a GEF for Cdc42, and structural studies revealed similarities in the GTPase-binding mechanisms used by Map and SifA ([@bib27]). Thus, these effectors appear to stimulate host GTPases by acting as GEFs and by possibly stabilizing GTPases in an active conformation. Lastly, the activities of type III effectors do not appear to be restricted to Rho family GTPases, as recent structural studies showed that the *E. coli* type III effector EspG binds ARF GTPases and p21-activated kinases, providing evidence for a unique GTPase--kinase signaling complex ([@bib56]).

Bacterial effectors that interfere with GTPase functions.
---------------------------------------------------------

Although activation of host GTPases can stimulate bacterial internalization and promote transport of vacuoles along novel pathways, deactivation of GTPases that promote internalization and transport of pathogens to lysosomes is an effective strategy to avoid destruction by phagocytes. Whereas direct activation of host GTPases by a bacterial effector is usually mediated by a GEF mimic, strategies available for deactivation of host GTPases are more diverse.

Similar to the mechanism used by eukaryotic cells to deactivate GTPases, many bacterial pathogens have been shown to encode effector proteins that function as GAPs. The SptP protein in *S.* Typhimurium and the LepB protein in *L. pneumophila* provide two examples ([@bib18]; [@bib30]). SptP has an N-terminal GAP domain that deactivates Rho GTPases ([@bib18]; [@bib59]; [@bib28]). SptP counteracts the GEF functions provided by the effectors SopE and SopE2, thereby reestablishing the actin cytoskeleton after uptake of *S.* Typhimurium ([Fig. 3 B](#fig3){ref-type="fig"}). Cytoskeletal stabilization provided by SptP is thought to maintain host cell integrity so that the vacuole containing *S.* Typhimurium can mature and support replication. The paradigm of a pathogen encoding a GAP that can counteract the activity of a bacterial GEF is also observed for LepB, which is a GAP that deactivates Rab1 ([Fig. 3 B](#fig3){ref-type="fig"}; [@bib30]). It is thought that Rab1 deactivation by the *L. pneumophila* LepB protein might promote the removal of Rab1 from the LCV, which may facilitate maturation of this organelle into an ER-like structure and prevent recruitment of Golgi matrix proteins. An *L. pneumophila* mutant deficient in LepB, however, has no dramatic defect in the dynamics of Rab1 cycling on the vacuole membrane, suggesting that there could be other effectors produced by *L. pneumophila* that influence the kinetics of Rab1 association with the vacuole.

A new mechanism by which bacteria can perturb the normal function of GTPases was revealed through studies on a type III effector from *Vibrio parahaemolyticus* called VopS ([Fig. 3 B](#fig3){ref-type="fig"}). This protein was shown to disrupt actin dynamics by interfering with the function of Rho GTPases ([@bib72]). The VopS protein sequence was found to harbor a conserved region of unknown function called a Fic domain. Genetic analysis showed that the VopS Fic region was essential for disrupting actin dynamics. The Fic region was determined to have an adenylyl transferase activity that enabled the VopS protein to use ATP as a substrate to posttranslationally modify host Rho family proteins through the covalent addition of the AMP moiety on a threonine residue in the switch I region of the GTPase, a process that was termed AMPylation. Similar results were obtained for a protein from *Histophilus somni* called IbpA ([@bib71]), which also has a Fic domain required for disrupting actin dynamics.

Recent structural studies on the *L. pneumophila* protein DrrA revealed a domain in this effector that was similar to the catalytic domain of glutamine synthetase adenylyl transferase, which is another enzyme that uses ATP as a substrate in an adenylylation reaction ([@bib44]). The DrrA adenylyl transferase domain was outside of the GEF domain in an N-terminal region of the protein shown to be extremely toxic to mammalian cells when produced ectopically ([@bib45]). Consistent with the structural predictions, DrrA was found to function as an adenylyl transferase and mediated the covalent attachment of AMP to a tyrosine residue in the switch II region of Rab1 ([Fig. 3 B](#fig3){ref-type="fig"}). Collectively, studies on VopS, IbpA, and DrrA reveal that AMPylation of GTPases represents a general strategy bacteria use to modulate signaling by host GTPases and can be mediated by structurally distinct effectors.

Two recent studies indicate that Rab1 AMPylation by DrrA can be reversed by an effector called SidD, which functions as a de-AMPylating enzyme ([Fig. 3 B](#fig3){ref-type="fig"}; [@bib47]; [@bib61]). These data suggest that *L. pneumophila* temporally regulate Rab1 AMPylation, which may be important for controlling the dynamics of Rab1 cycling on the vacuole. AMPylated Rab1 was found to be insensitive to deactivation by the GAP protein LepB, whereas de-AMPylated Rab1 regained sensitivity to GTP hydrolysis stimulated by LepB. Finding a de-AMPylating enzyme, in conjunction with the discovery that eukaryotic organisms also encode proteins with Fic domains, suggests that AMPylation could be a general mechanism to modulate GTPase functions endogenously.

Mass spectrometry was used to investigate modifications to Rab1 that occur during *L. pneumophila* infection of host cells, and this analysis revealed two different posttranslational modifications to Rab1 that are mediated by bacterial effector proteins ([@bib43]). In addition to Rab1 AMPylation mediated by DrrA, it was found that *L. pneumophila* also promotes the addition of a phosphocholine moiety onto the serine 79 residue in the switch II region of Rab1A, which is immediately adjacent to the AMPylated tyrosine 80 residue ([Fig. 3 B](#fig3){ref-type="fig"}). Interestingly, the *L. pneumophila* effector protein AnkX was found to be the enzyme directly responsible for Rab1 phosphocholination in a reaction that used cytidine diphosphate--choline as a substrate. This was unexpected because AnkX is a Fic domain--containing protein and was therefore predicted to function as an AMPylating toxin. Similar to the VopS adenylylation reaction, the phosphocholination reaction centers on Fic domain--dependent hydrolysis of the anhydrous bond in a diphosphoryl 5-ribose structure in the donor substrate. In addition to Rab1, AnkX was found to modify Rab35, which is a Rab1 subfamily member that is involved in membrane transport in the early endocytic pathway, suggesting how AnkX could modulate membrane transport in both the secretory and endocytic pathway. Protein phosphocholination had been demonstrated previously for the type IV pili protein of *Neisseria gonorrhoeae* ([@bib23]); however, studies on AnkX provide the first demonstration of direct protein phosphocholination by an effector protein and suggest that other Fic domain--containing effectors may function as phosphocholine transferases.

There are other examples of bacterial proteins that alter the covalent structure of GTPases to modulate their function. For example, large clostridial toxins, such as *Clostridium difficile* toxin A and toxin B and *Clostridium novyi* α toxin, are glycosyltransferases that modify the class I switch region of Rho, Rac, and Cdc42 ([@bib32]). A *Yersinia pestis* T3SS effector called YopT is a protease that cleaves a C-terminal residue in Rho GTPases to interfere with their function by removing the lipidation motif needed for association with membranes ([Fig. 3 B](#fig3){ref-type="fig"}; [@bib57]). Given the additional paradigms by which microbial factors can modulate Rho GTPases, it is likely that these and other strategies will be revealed for modulation of Rab GTPases and other membrane traffic regulators.

Conclusions and future perspectives
===================================

In addition to providing important details on the mechanism that pathogens use to infect host cells, the study of these organisms can also lead to a better understanding of normal cellular processes. Because sequential transport of membrane and cargo through eukaryotic cells is essential for the biogenesis and maintenance of distinct organelles, disruptions in membrane transport at a specific stage can indirectly affect biogenesis of multiple organelles in the cell, making it difficult to address the contribution of a host factor in a specific membrane transport process. In this regard, studying the mechanisms by which pathogens can manipulate membrane transport can be very insightful. For instance, the fact that the *L. pneumophila* DrrA protein is sufficient to recruit Rab1 to the vacuole in which the bacterium resides provides proof of principle that localization of a GEF is sufficient to mediate the accumulation of a specific Rab GTPase to an organelle. This is also true for localization of ARF mediated by RalF. Interestingly, these examples also show that localization of the active GTPase is not sufficient for the recruitment of cognate host effectors specific for the GTPase. In the case of RalF-mediated recruitment of ARF to vacuoles, it was initially surprising to find an organelle in the cell that was highly enriched for this GTPase that did not demonstrate the recruitment of coat proteins such as COPI, which are typically found on organelles displaying high levels of ARF. A similar example of a pathogen creating membrane domains enriched for ARF that were devoid of COPI was reported during infection of cells by coxsackievirus, and it was found that ARF was recruiting host PI4 kinase IIIβ to these membranes to generate a novel pool of PI4P that was recognized by viral proteins mediating genome replication ([@bib26]). Thus, studying pathogen manipulation of host membrane transport provides a unique perspective on how GTPases and their cognate effectors confer distinct properties to organelles.

The modulation of phosphoinositides, the cytoskeleton, and small GTPases represent common strategies for microbial manipulation of membrane transport; however, there are certainly additional strategies shared by other pathogens. Bacterial manipulation of tethering proteins, vesicular coats, and fusion factors, such as SNAREs, have emerged as other mechanisms to control membrane transport that have not been discussed but are equally interesting and important. Indeed, it is likely that bacteria have evolved mechanisms to mimic and control aspects of membrane transport that remain to be discovered by cell biologists. In this regard, studies that investigate bacterial manipulation of membrane transport will not only continue to advance our basic understanding of how intracellular pathogens create organelles that support replication but will also continue to advance our understanding of how normal cellular activities are regulated. In addition to discovering new activities that allow pathogens to subvert host cell functions, it is also important to understand how these proteins function in unity to generate the organelles in which microbes prosper. Determining how proteins with potentially antagonistic activities, such as DrrA and LepB, are regulated spatially and temporally is key to determining the stages in vacuole maturation in which their functions are most important. Along these same lines, it is important to more fully understand the function and eventual fate of proteins that are posttranslationally modified by microbial effectors. Thus, many interesting questions remain, and studies on microbial manipulation of host membrane transport should remain a fertile and exciting field for years to come.
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